SL
VERA icon

Siren LLC’s Vera Therapeutics VERA Stock Holding History

Siren LLC’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-247,216
Closed -$5.82M – 131
2025
Q2 		$5.82M Sell
247,216
-500,000
-67% -$11.2M 0.3% 56
2025
Q1 		$17.9M Sell
747,216
-11,249
-1% -$361K 1.01% 25
2024
Q4 		$32.1M Sell
758,465
-79,463
-9% -$3.52M 1.42% 21
2024
Q3 		$37M Buy
+837,928
New +$31.8M 1.85% 18

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Siren LLC's VERA Position: Q3 2025 in Review

Siren LLC sold out of Vera Therapeutics (VERA) in Q3 2025, closing a stake of 247,216 shares — an estimated $5.82M sold.

Siren LLC first reported a position in VERA in Q3 2024 and held it in 4 quarters. The position peaked at $37M in Q3 2024. 175 funds tracked by Wall St. Rank hold VERA as of Q3 2025.

  • Siren LLC reported no remaining Vera Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Siren LLC sold 247,216 Vera Therapeutics shares in Q3 2025, an estimated $5.82M.
  • Siren LLC first reported a position in Vera Therapeutics in Q3 2024 and held it in 4 quarters.
  • Siren LLC's Vera Therapeutics position peaked at $37M in Q3 2024.
  • 175 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2025.

Based on Siren LLC's 13F filing for Q3 2025, filed 13 Nov 2025.